The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome
Authors:
- 10 November 2004
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 204 (5) , 605-612
Abstract
Tenosynovial thickening within the confined space of the carpal tunnel is thought to be the cause of the carpal tunnel syndrome (CTS). However, little is known about the pathological mechanism of tenosynovial thickening. In this study, the role of prostaglandin E2 (PGE2) and vascular endothelial growth factor (VEGF) (two representative molecules that can induce oedema by increasing vascular permeability) was analysed in CTS by using immunohistochemistry and enzyme‐linked immunosorptive assay (ELISA). Expression of these molecules was compared with the patients' clinical histories and a temporary increase in production of these molecules was found in cells within the vessels and synovial lining during the intermediate phase of the syndrome when the histology of the tenosynovium changes from oedematous to fibrotic. Statistical analysis clearly demonstrated that there is a close correlation between the expression of PGE2 and VEGF. Furthermore, immunohistochemical analysis with anti‐proliferating cell nuclear antigen (PCNA) revealed that the area with distinct VEGF expression closely matched the area where endothelial cells, vascular smooth muscle cells, and synovial lining cells proliferate. In contrast, despite marked alteration in the extracellular matrix (ECM) component of the tenosynovium, the fibroblasts responsible for most ECM framework production do not proliferate during any phase of CTS. Histological analysis demonstrated that angiogenesis takes place only during the intermediate phase. Since clusters of capillaries and arterioles are often surrounded by type III collagen‐rich, disorganized, degenerate connective tissue, which contains fewer fibroblasts than normal, angiogenesis appears to take place as a part of a regenerative reaction that results in fibrosis. These findings strongly indicate that both PGE2 and VEGF are expressed in the tenosynovium in CTS during the intermediate phase and induce the histological changes seen in the tenosynovium. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- cDNA‐arrays and real‐time quantitative PCR techniques in the investigation of chronic achilles tendinosisJournal of Orthopaedic Research, 2003
- Increased Expression of Transforming Growth Factor-??1 in Patellar TendinosisClinical Orthopaedics and Related Research, 2002
- Time to abandon the "tendinitis" mythBMJ, 2002
- Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndromeMicrosurgery, 2002
- Rat Model of Achilles Tendon DisorderCells Tissues Organs, 1999
- Histopathology of Common TendinopathiesSports Medicine, 1999
- Correlation of MR imaging and pathologic findings in athletes undergoing surgery for chronic patellar tendinitis.American Journal of Roentgenology, 1995
- Pathology of the flexor tendon sheath in the spontaneous carpal tunnel syndromeJournal of Hand Surgery (European Volume), 1987
- Rheumatoid‐ and osteo‐arthritis: Quantitation of ultrastructural features of capillary endothelial cellsThe Journal of Pathology, 1986
- ANGIOGENIC FACTOR FROM SYNOVIAL FLUID RESEMBLING THAT FROM TUMOURSThe Lancet, 1980